Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease:  plasma concentrations exceed target levels, with drug accumulation in the most severe patients

BACKGROUND: TKM-130803 is a specific anti-EBOV therapeutic comprised of two small interfering RNAs (siRNA) siLpol-2 and siVP35-2. The pharmacokinetics (PK) of these siRNAs was defined in Ebola virus disease (EVD) patients, with reference to efficacy (ET) and toxicology thresholds (TT). The relations...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Janet T., Sharma, Raman, Meredith, Luke W., Dunning, Jake, Moore, Catrin E., Sahr, Foday, Ward, Steve, Goodfellow, Ian, Horby, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033524/
https://www.ncbi.nlm.nih.gov/pubmed/31953031
http://dx.doi.org/10.1016/j.ebiom.2019.102601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033524/
https://www.ncbi.nlm.nih.gov/pubmed/31953031
http://dx.doi.org/10.1016/j.ebiom.2019.102601

Ejemplares similares